| 產(chǎn)品編號 | bs-1971R |
| 英文名稱 | Lxn Rabbit pAb |
| 中文名稱 | 羧肽酶抑制劑抗體 |
| 別 名 | ECI; Endogenous carboxypeptidase inhibitor; Latexin protein; MUM; TCI; Tissue carboxypeptidase inhibitor; LXN_HUMAN. |
| 研究領(lǐng)域 | 細(xì)胞生物 干細(xì)胞 合成與降解 |
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | Mouse,Rat (predicted: Human,Rabbit,Pig,Cow,Horse) |
| 產(chǎn)品應(yīng)用 | WB=1:500-2000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | 25 kDa |
| 檢測分子量 | |
| 細(xì)胞定位 | 細(xì)胞漿 |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human Lxn: 131-222/222 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 |
Latexin, a protein possessing inhibitory activity against rat carboxypeptidase A1 (CPA1) and CPA2, is expressed in a neuronal subset in the cerebral cortex and cells in other neural and non-neural tissues of rat. Although latexin also inhibits mast-cell CPA (MCCPA), the expression of latexin in rat mast cells has not previously been confirmed. Subcellular Location: Cytoplasm. Tissue Specificity: Highly expressed in heart, prostate, ovary, kidney, pancreas, and colon, moderate or low in other tissues including brain. Similarity: Belongs to the protease inhibitor I47 (latexin) family. SWISS: Q9BS40 Gene ID: 56925 Database links: Entrez Gene: 56925 Human Entrez Gene: 17035 Mouse Omim: 609305 Human SwissProt: Q9BS40 Human SwissProt: P70202 Mouse Unigene: 478067 Human Unigene: 2632 Mouse Unigene: 11404 Rat Latexin的靶蛋白為羧肽酶，Latexin與炎癥的發(fā)展密切相關(guān)，主要表達于單核巨噬細(xì)胞。 |
| 產(chǎn)品圖片 |
25 ug total protein per lane of various lysates (see on figure) probed with Lxn polyclonal antibody, unconjugated (bs-1971R) at 1:500 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.
|
